IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
IDEXX Laboratories (NASDAQ:IDXX) has had a rough three months with its share price down 9.0%. But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially see an increase in value in the long-term, given how markets usually reward companies with good financial health. Particularly, we will be paying attention to IDEXX Laboratories' ROE today.
IDEXX Laboratories (納斯達克股票代碼：IDXX) 的股價在過去的三個月中有所下跌。但是，如果您仔細觀察，可能會發現其強大的財務狀況意味着長期來看，該股票可能會有價值上漲的潛力，因爲市場通常會獎勵那些有良好財務狀況的公司。特別是，今天我們將關注IDEXX Laboratories的roe表現。
ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. Simply put, it is used to assess the profitability of a company in relation to its equity capital.
roe或股東權益回報率是評估公司如何有效地從股東那裏獲得回報的有用工具。簡而言之，它用於評估公司相對於其權益資本的盈利能力。
How Is ROE Calculated?
淨資產收益率怎麼計算？
Return on equity can be calculated by using the formula:
股東權益報酬率可以使用以下公式計算：
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
淨資產收益率 = 淨利潤（從持續經營中獲得）÷ 股東權益
So, based on the above formula, the ROE for IDEXX Laboratories is:
因此，根據上述公式，IDEXX Laboratories的ROE爲：
55% = US$867m ÷ US$1.6b (Based on the trailing twelve months to March 2024).
55％= US $ 867m ÷ US $ 1.6b（基於截至2024年3月的過去十二個月）。
The 'return' is the income the business earned over the last year. One way to conceptualize this is that for each $1 of shareholders' capital it has, the company made $0.55 in profit.
'回報'是企業上一年獲得的收入。理解這一點的一種方式是，對於每1美元的股東資本，公司賺了0.55美元的利潤。
Why Is ROE Important For Earnings Growth?
ROE對於盈利增長的重要性是什麼？
Thus far, we have learned that ROE measures how efficiently a company is generating its profits. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes.
到目前爲止，我們已經了解到ROE衡量公司利潤的效率如何。基於公司選擇再投資或保留多少利潤，我們隨後能夠評估公司未來產生利潤的能力。總的來說，在其他條件相等的情況下，具有高ROE和利潤保留的公司的增長率比沒有這些特徵的公司要高。
A Side By Side comparison of IDEXX Laboratories' Earnings Growth And 55% ROE
IDEXX Laboratories盈利增長和55％roe的並排比較
Firstly, we acknowledge that IDEXX Laboratories has a significantly high ROE. Second, a comparison with the average ROE reported by the industry of 11% also doesn't go unnoticed by us. Probably as a result of this, IDEXX Laboratories was able to see a decent net income growth of 15% over the last five years.
首先，我們認識到IDEXX Laboratories的ROE非常高。 其次，該行業平均roe爲11％，我們也注意到了這一點。 可能由於這個原因，IDEXX Laboratories在過去五年中淨利潤增長了15％。
We then compared IDEXX Laboratories' net income growth with the industry and we're pleased to see that the company's growth figure is higher when compared with the industry which has a growth rate of 8.7% in the same 5-year period.
然後我們將IDEXX Laboratories的淨利潤增長與該行業進行了比較，發現在同一個5年期內，IDEXX Laboratories增長率較高，行業增長率爲8.7％。
Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. Is IDEXX Laboratories fairly valued compared to other companies? These 3 valuation measures might help you decide.
盈利增長是估值股票時要考慮的重要指標。投資者應該嘗試確定預期的盈利增長或下降是否被計價。通過這樣做，他們會知道該股票是前往清澈藍色的水域還是沼澤地的水域。與其他公司相比，IDEXX Laboratories定價是否公正？這三種估值方法可能會幫助您做出決策。
Is IDEXX Laboratories Using Its Retained Earnings Effectively?
IDEXX Laboratories是否有效利用了其留存收益？
IDEXX Laboratories doesn't pay any regular dividends, meaning that all of its profits are being reinvested in the business, which explains the fair bit of earnings growth the company has seen.
IDEXX Laboratories沒有支付常規股息，這意味着其所有利潤都被再投資到業務中，這就解釋了公司已經看到的相當多的盈利增長。
Summary
總的來說，我們對偉明環保的表現非常滿意。具體而言，我們喜歡公司以高回報率再投資了其利潤的很大一部分。當然，這導致公司的收益大幅增長。但是，最新的行業分析師預測表明，該公司的收益預計將加速增長。
In total, we are pretty happy with IDEXX Laboratories' performance. In particular, it's great to see that the company is investing heavily into its business and along with a high rate of return, that has resulted in a sizeable growth in its earnings. Having said that, the company's earnings growth is expected to slow down, as forecasted in the current analyst estimates. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.
總體而言，我們對IDEXX Laboratories的表現感到非常滿意。特別是，很不錯地看到公司正在大力投資其業務，並且在高回報率的情況下，這導致了其盈利的大幅增長。不過，需要指出的是，根據當前分析師的預測，公司的盈利增長有望放緩。請查看有關該公司未來盈利增長預測的免費報告，了解更多信息。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋？關於內容有所顧慮？直接和我們聯繫。或者，發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論，只使用公正的方法論，我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議，也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意，我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
譯文內容由第三人軟體翻譯。